Evercore ISI Upgrades Teva Pharma (TEVA) to Outperform, 'TL1A & pipeline in focus'
Tweet Send to a Friend
(Updated - May 18, 2023 7:55 AM EDT)
Evercore ISI analyst Umer Raffat upgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
Evercore ISI analyst Umer Raffat upgraded Teva Pharma (NYSE: TEVA) from ...
This is a premium only article. To continue reading this and other premium stock market news articles please sign-in or upgrade to StreetInsider.com Premium below (Free Trial) LEARN MORE
